Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer
This study is ongoing, but not recruiting participants.
Study NCT00399529
Information provided by Sidney Kimmel Comprehensive Cancer Center
First Received: November 13, 2006
Last Updated: August 31, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
